MIFH
CDAK

Migdal Insurance & Financial Holdings’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-341
Closed -$4K – 717
2021
Q4 		$4K Sell
341
-204
-37% -$2.83K ﹤0.01% 658
2021
Q3 		$9K Buy
+545
New +$9.75K ﹤0.01% 611

Other funds holding CDAK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.44B AUM 23.16% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Migdal Insurance & Financial Holdings's CDAK Position: Q1 2022 in Review

Migdal Insurance & Financial Holdings sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q1 2022, closing a stake of 341 shares — an estimated $4K sold.

Migdal Insurance & Financial Holdings first reported a position in CDAK in Q3 2021 and held it in 2 quarters. The position peaked at $9K in Q3 2021. 62 funds tracked by Wall St. Rank hold CDAK as of Q1 2022.

  • Migdal Insurance & Financial Holdings reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 341 Codiak BioSciences, Inc. Common Stock shares in Q1 2022, an estimated $4K.
  • Migdal Insurance & Financial Holdings first reported a position in Codiak BioSciences, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Codiak BioSciences, Inc. Common Stock position peaked at $9K in Q3 2021.
  • 62 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q1 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2022, filed 2 May 2022.